Yifan Zhai
Director Técnico/Científico/I+D en ASCENTAGE PHARMA GROUP INTERNATIONAL .
Fortuna: 148 M $ al 30/04/2024
Perfil
Yifan Zhai is a Chief Medical Officer at Ascentage Pharma Group International Co., Ltd.
She previously held positions as Director-Pharmacology Department at Exelixis, Inc., President at HealthQuest, Inc., Chief Scientific Officer at Celladon Corp.
and Oncomax Acquisition Corp.
She was also President of The Chinese Biopharmaceutical Association.
She worked as a Principal at Human Genome Sciences, Inc. and Bayer Pharmaceuticals Corp.
Zhai holds a doctorate degree from Michigan State University and Sun Yat-Sen University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 27/10/2023 | 64 585 929 ( 22.25% ) | 148 M $ | 30/04/2024 |
Cargos activos de Yifan Zhai
| Empresas | Cargo | Inicio |
|---|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Director Técnico/Científico/I+D | 01/07/2013 |
Antiguos cargos conocidos de Yifan Zhai.
| Empresas | Cargo | Fin |
|---|---|---|
| The Chinese Biopharmaceutical Association | Presidente | 01/01/2010 |
Celladon Corp.
 Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | Director Técnico/Científico/I+D | 01/01/2010 |
| Oncomax Acquisition Corp. | Director Técnico/Científico/I+D | 01/01/2007 |
HealthQuest, Inc.
 HealthQuest, Inc. Medical/Nursing ServicesHealth Services HealthQuest, Inc. provides health care and well-being awareness services. The company is headquartered in Palm Beach Gardens, FL. | Presidente | 01/01/2005 |
| EXELIXIS, INC. | Corporate Officer/Principal | 01/01/2003 |
Formación de Yifan Zhai.
| Michigan State University | Doctorate Degree |
| Sun Yat-Sen University | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Health Technology |
| Empresas privadas | 6 |
|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | Health Technology |
| Bayer Pharmaceuticals Corp. | |
HealthQuest, Inc.
HealthQuest, Inc. Medical/Nursing ServicesHealth Services HealthQuest, Inc. provides health care and well-being awareness services. The company is headquartered in Palm Beach Gardens, FL. | Health Services |
| The Chinese Biopharmaceutical Association | |
| Oncomax Acquisition Corp. |
- Bolsa de valores
- Insiders
- Yifan Zhai